{"id":"NCT01017874","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer","officialTitle":"A Randomized Ph 3 Study Comparing First-Line Pemetrexed/Cisplatin Followed by Gefitinib With Gefitinib Alone in East Asian Never Smoker or Light Ex-Smoker Patients With Locally Advanced or Metastatic Nonsquamous NSCLC","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11","primaryCompletion":"2013-04","completion":"2014-10","firstPosted":"2009-11-23","resultsPosted":"2014-04-03","lastUpdate":"2015-07-08"},"enrollment":236,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Pemetrexed","otherNames":["Alimta","LY231514"]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"Gefitinib","otherNames":[]},{"type":"DRUG","name":"Gefitinib","otherNames":[]}],"arms":[{"label":"Pemetrexed + Cisplatin + Gefitinib","type":"EXPERIMENTAL"},{"label":"Gefitinib","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare two different approaches to treating non-small cell lung cancer (NSCLC) in East Asian never-smoker participants. Half of the participants will receive chemotherapy (pemetrexed/cisplatin) followed by an oral anti-cancer agent (gefitinib) and the other half of the participants will receive only the oral anti-cancer agent (gefitinib).","primaryOutcome":{"measure":"Progression Free Survival (PFS)","timeFrame":"Randomization to the first date of measured PD or death up to 37.32 months","effectByArm":[{"arm":"Pemetrexed + Cisplatin + Gefitinib","deltaMin":8.38,"sd":null},{"arm":"Gefitinib","deltaMin":9.63,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.217"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":12,"countries":["Hong Kong","Singapore","South Korea","Taiwan","Thailand"]},"refs":{"pmids":["26725183","26511807","24953333"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":114},"commonTop":["Nausea","Rash","Diarrhoea","Decreased appetite","Pruritus"]}}